Staff Profile:
- Name:
- Dr. Giampiero Favato
- Role:
-
Senior Lecturer; Subject Area Leader, Corporate Finance and Governance
- School:
- Projects, Processes and Systems
- Academic Profile:
- DBA, AdipC, MBA,
- Areas of Expertise:
- Governance of Public Health, Valuation of Intangible Assets, Quantitative Finance, Real Options Pricing.
Professional Expertise:
- For over a period of nearly two decades, Giampiero has had increasing financial and strategic responsibilities in the Life Science industry. This was ultimately as a Director in one of the leading research-based pharmaceutical companies, where he was leading global teams dedicated to innovation and change. He is currently involved in the governance of non-profit health research organisations, serving as a Board Member of SEFAP, the epidemiology research centre of the University of Milan, and the Phoenix Stem Cell Foundation for Human Life. Giampiero is a Member of the Corporate Finance Faculty at the Institute of Chartered Accountants in England and Wales (ICAEW), and a Visiting Faculty at the "Statale" and the "Bicocca", the two public Universities in Milan.
- Research:
- Giampiero has conducted some pioneering research using Real Option pricing models to valuate pharmaceutical R&D projects. His current academic research interests focus on governance of public health and managerial relevance of Corporate Governance.
- Expert opinion:
- Valuation of intangible assets in pharmaceutical R&D.
- Publications:
Click to hide publications
Recent Books
G. Favato and C. Print (2008), Corporate Finance Decisions in Volatile Economic Times, London, Cognita, ISBN: 978-0-9558523-05
The aim of this book is to help managers to reflect upon the critical assumptions underlying the most relevant tools for valuation of corporate investments under uncertainty. ]
click to open in a new window (File size:636kb)
Recent Book SectionsG. Favato (2009) Consortium stretches the limits of hostile takeover, in A. Bonham, K. Langdon (eds) Fast track to success: finance, FT Prentice Hall - Pearson Education, p112-114.
G. Favato (2009) Value drivers of corporate deals, in A. Bonham, K. Langdon (eds) Fast track to success: finance, FT Prentice Hall - Pearson Education, p131-132.
Recent Conference PapersG Favato, F S Mennini, A Monorchio, E Mortilla (2009) Anti-HPV Vaccination in Italy: Comparison of Recent Economic Evidences In: iHEA 7th World Congress on Health Economics, Beijing 12-15 July
G Favato, V Pieri (2009) Hypolipidemic agents in chronic therapy. A compliance study in the Italian ASSET cohort In: Pharmscifair Abstract INV-70 , Nice (France) 8-12 June
G. Favato (2009) Long term sustainability of SSN pharmaceutical coverage in Italy. A twenty year outlook (2005-2025) In: III Congresso Nazionale SITeCS. Naples 22-24 January. Edited by: Prof. A. Catapano.
J. A. Stewart and G. Favato (2007) Compliance in the supply chain: the present and future implications of Sarbanes-Oxley for UK businesses. Paper presented at the 10th International Conference on Corporate Governance & Board Leadership, Henley Management College, October 2007.
G. Favato, V. Pieri and R.W. Mills (2007), "Cost/Effective Analysis of Anti-HPV Vaccination Programme in Italy”. Paper presented at the conference Infezione da HPV: Approccio Multidisciplinare, Rome, 25 May 2007.
G. Favato, R.W. Mills, B. Weinstein (2007) Estimating the Cost of Clinical Innovation: Parametric Analysis of Late Stage Pharmaceutical R&D. Paper presented at the R&D Management Conference 2007, Risk and Uncertainty in R&D management, Bremen, Germany, 4-6 July 2007, ISBN: 0-9549916-9-9
G. Favato (2007) Farmacoutilizzazione: i data italiani. Paper presented at the conference Malattie cardiovascolari: nuove propsettive nella fisiopatologia e terapia, II National Congress of the Italian Society of Clinical and Experimental Therapy (SIRTEC), Naples, 7-9 October 2007.
G. Favato, P Mariani, R.W. Mills, M. Pelagatti, A.L. Catapano (2007) Knowledge-based governance can improve the elderly population’s equity of access to public pharmaceutical funding. Paper presented at the 10th International Conference on Corporate Governance & Board Leadership, Henley Management College, October 2007.
G. Favato G (2007) Outcomes of the ASSET study. Paper presented at the 1st SEFAP Scientific Board Meeting, Milan, September 2007.
Recent Henley Discussion PapersG. Favato, V. Pieri and R.W. Mills (2007), Cost/Effective Analysis of anti-HPV Vaccination Programme in Italy: a Multi-Cohort Markov Model, Henley Discussion Paper Series (HCVI HDP No. 13, February 2007). The paper was also made available via the Social Research Network (SRN), making the top ten list of top downloaded papers in health economics just after few days.)
G. Favato, P. Mariani, R.W. Mills, A. Capone, M. Pelagatti, V. Pieri, A. Marcobelli, M.G.Trotta, A. Zucchi and A.L. Catapano (2007) Equating population demographics and therapeutic needs with pre prescribing costs: The ARTE (Age/Sex Related Therapeutic Estimates) research model. Henley Discussion Paper Series (HCVI HDP No. 17, May 2007).
G. Favato, P. Mariani, R.W. Mills, A. Capone, M. Pelagatti, V. Pieri, A. Marcobelli, M.G.Trotta, A. Zucchi and A.L. Catapano (2007) Impact of Ageing on Prescribing Demand, Henley Discussion Paper Series (HCVI HDP, No. 14, February)
R. W. Mills, W. Weinstein, G. Favato and A. Bohl (2006) Employee Benefits - a Potential Source of Value to Business, HCVI HDP No.12.
G. Favato, R. W. Mills and W. Weinstein (2005) Real Option Taxonomies and their implications for management practice. Henley Centre for Value Improvement, Henley Discussion Paper. No 10. Available at http://www.henleymc.ac.uk/hcvi
G. Favato, R. W. Mills and W. Weinstein (2004) Parametric Cost Analysis of Late-stage Pharmaceutical Development - Reducing Risk in Go/No Go Decisions. Henley Centre for Value Improvement, Henley Discussion Paper. No 6. Available at http://www.henleymc.ac.uk/hcvi
Recent Henley Working PapersG. Favato, C. F. Print, R. Mills, W. Weinstein (2008) Estimating the Direct Costs of Developing New Drugs, HWP 0804
Recent Journal ArticlesG Favato (2009) A quantum of leadership Devil's Advocates, Financial Services Skills Council
Available online at:
http://www.fssc.org.uk/642_5.html?i=5#1F.S. Mennini, S. Costa, G. Favato and S. Picardo (2009). Anti-HPV vaccination: A review of recent economic data for Italy. Vaccine 27: Supplement 1. A54-A61 May
J.A. Stewart, M. Day, C.F. Print, and G. Favato (2009) Compliance in the Supply Chain: Implications of Sarbanes-Oxley for UK Businesses. The Icfai University Journal of Supply Chain Management, Vol. 6, No. 1, pp. 7-19, March 2009.
L. Jassur, G. Favato, C. Print (2009) The flaws of securitisation, International Journal of Corporate Governance, Vol 1, No 4, pp 400-417
G. Favato and C. Print (2008). 2002 mortality rate for coronary heart disease in Italy: a statistical outlier or a sentinel event? Heart, Feb 27
J.A. Stewart, G. Favato, M. Day, C.F. Print (2008) Compliance in the supply chain: implications of Sarbanes-Oxley for UK businesses, ICFAI Journal of Supply Chain Management. pp 1 -21
G. Favato , P. Mariani, C.F. Print , A. Capone, M. Pelagatti, V. Pieri, A. Marcobelli, E. Tragni, M.G. Trotta, A. Zucchi and A.L. Catapano (2008). Effect of age and sex related therapeutic needs on general practices' prescribing costs. The ASSET (Age/Sex Standardised estimates of treatment) research model. Pharmacoeconomics - Italian Research Articles. 10(2): 89-98.
G. Favato (2008), High Incidence of Smoking Habit in Psoriatic Patients. Am J Med doi:10.1016/j.amjmed.2007.12.007
G. Favato and C. Print (2008). Real Investment Options: A Case Illustration. Management Online Review, ESCP-EAP European School of Management. ISSN: 1996-3300. Available online at:
http://www.morexpertise.com/browse/2G. Favato (2008) Relevance of Real Options to Corporate Investment Decisions, IJDM, The Icfai University Journal of Derivatives Markets, Vol.5, No.3, pp-91-103.
G. Favato (2008) Rilevanza delle variazioni demografiche di farmaco-utilizzazione per il governo della spesa farmaceutica pubblica. Giornale Italiano di Farmacoeconomia e Farmacoutilizzazione, 1(2): 22-29.
G. Favato, V. Pieri, and R.W. Mills (2007), Analisi costo-efficacia del programma di vaccinazione anti-HPV in Italia: il modello multi-coorte Markov, Farmaci, Vol. 31 – n2/2007.
G. Favato, P. Mariani, R.W. Mills, A. Capone, M. Pelagatti et al. (2007) ASSET (Age/Sex Standardised Estimates of Treatment): A Research Model to Improve the Governance of Prescribing Funds in Italy. PLoS ONE 2(7): e592. doi:10.1371/journal.pone.0000592
G. Favato, R.W. Mills and B. Weinstein (2007) Estimating the cost of clinical innovation: parametric analysis of late stage pharmaceutical R&D, Int. J. Technology Intelligence and Planning, Vol. 3, No. 3, pp: 233-245.
G. Favato and R. W. Mills (2007) Identifying best practices in cost management , Henley Manager Update, Vol 18, No 3, Spring, p43-52
G. Favato and A.L. Catapano (2007) Editorial: Old people and drug prescription in Italy. Results of The ASSET study. G. GERONTOL; 55: 191-192.
G. Favato and R.W. Mills (2007), Parametric Cost Analysis, ICAEW Finance and Management Manager Update, Issue 40, February, pp 13-16.
G. Favato and R.W. Mills (2007), The Long Tail of healthcare and the impact of the web. ICAEW Finance and Management Manager Update, Issue 42, July.
G. Favato G and R. W. Mills (2007), Will the web change the economics of the pharmaceutical industry? Henley Manager Update, Vol. 18, No. 4., Summer, pp. 29-37.
G. Favato and R.W. Mills (2006/2007), How to manage big budgets, Henley Manager Update, Vol. 18, No. 2, Winter, pp 45-53.
G. Favato, R. W. Mills (2006) Challenging conventional wisdom in R&D, Henley Manager Update, Vol.18 No. 1 Autumn, 55-64
R. W. Mills, B. Weinstein and G. Favato (2006) Using scenario thinking to make real options relevant to managers: a case illustration. Journal of General Management, 31 (3), Spring 2006, 49-74.
Recent OthersG. Favato (2008) A Multi-Cohort Markov Model of Anti-HPV Vaccination Programme. BMJ, April 29. Available online at:
http://www.bmj.com/cgi/eletters/bmj.39555.668229.80v1Mamarbachi, R., Day, M., and Favato, G., (2008) Art as an Alternative Investment Asset (March 26 2008). Available at SSRN:
http://ssrn.com/abstract=1112630 G. Favato (2008) Consortium Strategy: Stretching the Limits of Hostile Takeovers." (April 8, 2008). Available at SSRN:
http://ssrn.com/abstract=1116693G. Favato, P. Mariani, C.F. Print, A. Capone, M. Pelagatti, V. Pieri, A. Marcobelli, E. Tragni, M.G. Trotta, A. Zucchi, and A. Catapano (2008) Effect of Age and Sex Related Therapeutic Needs on General Practices' Prescribing Cost: The ASSET (Age/Sex Standardised Estimates of Treatment) Research Model. Available at SSRN
G. Favato (2008) Is age the key determinant of prescribing demand? Results from the ASSET (Age/Sex Standardised Estimates of Treatment) study. BMJ, April 28. Available online at:
http://www.bmj.com/cgi/eletters/336/7644/606G. Favato, P. Mariani, C.F. Print, A. Capone, M. M. Pelagatti, V. Pieri, A. Marcobelli, E. Tragni, G. Trotta, A. Zucchi and A. Catapano (2008) Knowledge-Based Governance Can Improve the Elderly Population's Equity of Access to Public Pharmaceutical Funding: The ASSET (Age/Sex Standardised Estimates of Treatment) Research Model. Available at SSRN
G. Favato and C.F. Print (2008) Real Investment Options: A Case Illustration (April 8, 2008). Available at SSRN:
http://ssrn.com/abstract=1117262G. Favato (2008) Relevance of Real Options to Corporate Investment Decisions (April 06, 2008). Available at SSRN:
http://ssrn.com/abstract=1116743J.A. Stewart and G. Favato (2007) Compliance in the supply chain: The present and future implications of Sarbanes-Oxley for UK businesses, June 6. Available at SSRN:
http://ssrn.com/abstract=994288G. Favato, V. Pieri and R.W. Mills (2007) Cost/Effective Analysis of Anti-HPV Vaccination Programme in Italy: A Multi-Cohort Markov Model, February. Available at SSRN:
http://ssrn.com/abstract=961847R. Mills, B. Weinstein and G. Favato (2007) "Financial Options and the Scandal of Banca Popolare Italiana (BPI): An Overnight Business Case" August. Available at SSRN:
http://ssrn.com/abstract=1012630G. Favato (2007), Rapid Responses: Social solidarity can compensate for income inequalities: the case of the public Italian healthcare service, BMJ, 10 Nov
G. Favato and R. Mills (2007) Real Options for Playstation, Available at SSRN:
http://ssrn.com/abstract=1012663Favato G, Print C L, Mills R W (2007). The Italian public investment on statins seems to yield a lower than expected return. Rapid Responses to DR. FOSTER'S CASE NOTES: Majeed A, Ayilin P, Williams S et al. Prescribing of lipid regulating drugs and admissions for myocardial infarction in England. BMJ 2004; 329:645. Available online at:
http://www.bmj.com/cgi/eletters/329/7467/645G. Favato and R. Mills (2007) Thinking the Unthinkable: Modern Non-Parametric Re-sampling Methods, August. Available at SSRN:
http://ssrn.com/abstract=1012661G. Favato and R.W. Mills (2007) Valuation of Intangible Assets: Estimating Late-Stage Development Cost of Pharmaceutical R&D, August. Available at SSRN:
http://ssrn.com/abstract=1012639G. Favato, R.W. Mills and B. Weinstein (2007) What Do a Space Shuttle and an Anti-Cancer Drug Have in Common? Their Development Costs Can Be Estimated Using Parametric Cost Analysis A Literature Review . Available at SSRN:
http://ssrn.com/abstract=1012647
Recent ReportsJ.A. Stewart and G. Favato (2007) Compliance in the supply chain; the present and future implications of Sarbanes-Oxley for UK businesses, Research report published by Microsoft, pp 1-33.